Showing results (601-610 of 1,813) with videos related to

Sort By:
Pageof 182
Transplantation and Cellular Therapy|April 8, 2021
Meeting the Demand for Unrelated Donors in the Midst of the COVID-19 Pandemic: Rapid Adaptations by the National Marrow Donor Program and Its Network Partners Ensured a Safe Supply of Donor ProductsJeffery J Auletta, Jen L Novakovich, Gretta L Stritesky, et al.
Transplantation and Cellular Therapy|April 8, 2021
Impact of Novel Targeted Therapies and Cytogenetic Risk Groups on Outcome After Allogeneic Transplantation for Adult ALLZaid H Abdel Rahman, Michael G Heckman, Kevin Miller, et al.
Transplantation and Cellular Therapy|April 8, 2021
Effect of Keratinocyte Growth Factor on Hospital Readmission and Regimen-Related Toxicities after Autologous Hematopoietic Cell Transplantation for LymphomaNajla El Jurdi, Christina Fair, John Rogosheske, et al.
Transplantation and Cellular Therapy|March 29, 2021
Use of Backup Stem Cells for Stem Cell Boost and Second Transplant in Patients with Multiple Myeloma Undergoing Autologous Stem Cell TransplantationEmily C Liang, Lori S Muffly, Parveen Shiraz, et al.
Transplantation and Cellular Therapy|March 29, 2021
Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United StatesJoseph McGuirk, Clint Divine, Seung Hyun Moon, et al.
Transplantation and Cellular Therapy|March 29, 2021
Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell TransplantationNosha Farhadfar, Ajoy Dias, Tao Wang, et al.
Transplantation and Cellular Therapy|March 30, 2021
The International Prognostic Index Is Associated with Outcomes in Diffuse Large B Cell Lymphoma after Chimeric Antigen Receptor T Cell TherapyMarta Garcia-Recio, Kitsada Wudhikarn, Martina Pennisi, et al.
Transplantation and Cellular Therapy|March 30, 2021
Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective StudyBeatrice Anna Zannetti, Francesco Saraceni, Claudia Cellini, et al.
Transplantation and Cellular Therapy|March 30, 2021
Allogeneic Hematopoietic Cell Transplantation for Relapsed and Refractory Philadelphia Negative B Cell ALL in the Era of Novel Salvage TherapiesIbrahim Aldoss, Dongyun Yang, Monzr M Al Malki, et al.
Transplantation and Cellular Therapy|March 30, 2021
Chlorhexidine Gluconate Bathing Reduces the Incidence of Bloodstream Infections in Adults Undergoing Inpatient Hematopoietic Cell TransplantationVinay K Giri, Kristin G Kegerreis, Yi Ren, et al.
Pageof 182